IgE-targeted Therapies and the Future Management of Food Allergies
Released On
February 29, 2024
Expires On
March 01, 2025
Media Type
Internet
Completion Time
45 minutes
Specialty
Allergy & Immunology, Pediatrics, Primary Care
Topics
Pediatrics
This activity is jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the Asthma and Allergy Foundation of America (AAFA), and Food Allergy Research & Education (FARE).
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.
Date of Release/Expiration
This activity was released on February 29, 2024 and is valid until March 1, 2025. Requests for credit must be made no later than March 1, 2025.
Credit Available
- Physicians - maximum of 0.75 AMA PRA Category 1 Credits™
Target Audience
The primary target audience for this activity are Allergy/Immunology, Pediatrics (MD/DO/NP/PA). The secondary target audience are Primary Care providers (MD/DO/NP/PA).
Program Overview
The standard of care for people with food allergies continues to be strict allergen avoidance of offending foods and reactive management of symptoms with emergency medications. However, total allergen avoidance is challenging. There is a critical need for new approaches that improve outcomes for patients with food allergies. Immunoglobulin E (IgE) plays a critical role in the pathophysiology of food allergies and anti-IgE monoclonal antibodies are promising emerging therapeutic agents. Join an expert panel of an allergist/immunologist and a primary care physician to discuss the diagnostic process for food allergies, the risks and benefits of current management options for patients and their caregivers, and the role of biologics for patients with and without comorbidities.
Learning Objectives
- Clarify recommendations for the diagnosis and management of food allergies
- Recognize the limitations and challenges faced by patients relying on allergen avoidance or using immunotherapy to manage food allergies
- Summarize current evidence on the efficacy, safety, and place in therapy of emerging biologics that target the underlying IgE-driven pathophysiology of food allergies and common associated comorbidities
- Discuss the place in care of agents targeting IgE and the role of shared decision-making in the management of people with food allergies
Faculty
Edwin Kim, MD, MS
Associate Professor of Pediatrics
University of North Carolina School of Medicine
Ruchi Gupta, MD, MPH
Professor of Pediatrics & Medicine, Northwestern
University Feinberg School of Medicine
Clinical Attending, Ann & Robert H. Luri
Children’s Hospital of Chicago
Director, Center for Food Allergy & Asthma Research (CFAAR)
Kristie C. Herring
Caregiver Penalist
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
PACE designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Time to Complete
This activity should take approximately 45 minutes to complete.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Faculty and Disclosures of Conflicts Of Interest
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Accreditation Support:
For additional information about the accreditation of this activity, please visit https://partnersed.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or [email protected].
PlatformQ Health Privacy Policy
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/